quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:30:36·36d
SECFiling
Dogwood Therapeutics Inc. logo

SEC Form 10-K filed by Dogwood Therapeutics Inc.

DWTX· Dogwood Therapeutics Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • DWTX
    Dogwood Therapeutics Inc.
    Health Care

Related

  • PR23h
    Dogwood Therapeutics Announces Worldwide Development and Commercialization Partnership for Anti-Viral Assets with Potential Value up to $100M
  • SEC6d
    SEC Form PRE 14A filed by Dogwood Therapeutics Inc.
  • PR8d
    Dogwood Therapeutics Announces FDA Acceptance of SP16 Investigational New Drug Application for the Treatment of Chemotherapy Induced Pain and Neuropathy
  • SEC28d
    Dogwood Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • SEC36d
    Dogwood Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR36d
    Dogwood Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
  • SEC42d
    Dogwood Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
  • INSIDER48d
    SEC Form 4 filed by SVP OF OPERATIONS Grosswald Ralph
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022